Program
The conference will highlight recent developments in key areas of metabolism, diabetes and its complications. We envision contributions allowing the audience to gain an overview of the exciting progress on these fundamental topics by speakers known for their outstanding contributions to this field.
The conference will cover current topics from various fields in diabetes research in the following four sessions:
- Session I: Clinical Management of Diabetic Complications
- Session II: Mechanisms in Diabetic Complications
- Session III: (Epi)Genetics and adipose tissue
- Session IV: Glucose Control by beta cells
Thursday, November 16th
| 08.00 - 08.50 | Registration |
| 08.50 | Welcome Stephan Herzig, Helmholtz Center Munich, Institute for Diabetes and Cancer, Munich |
| 09.00 - 12.30 | Session I: Clinical Management of Diabetic Complications |
| 09.00 | Metabolic Surgery to Reduce Complications of Type 2 Diabetes: Results of the STAMPEDE Trial Philip R. Schauer, Cleveland Clinic, Cleveland, USA |
| 09.30 | Mitochondrial sulfide therapy in the diabetic context: does inhibiting endogenous breakdown offer a new strategy? Nicholas M. Morton, University of Edinburgh, Edinburgh, UK |
| 10.00 | Signaling redundancy of the insulin receptor and coagulation protease receptors provide a new therapeutic approach to diabetic nephropathy Berend Isermann, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany |
| 10.30 | Coffee break |
| 11.00 | Retinal vascular barrier in diabetes: novel aspects and treatment targets Reinier O. Schlingemann, Academic Medical Center, University of Amsterdam, Netherlands |
| 11.30 | Diabetic Retinopathy starts as a Neuropathy Michael D. Abramoff, UI Carver College of Medicine, Iowa City, USA |
| 12.00 - 12.30 | Short Talks I |
| 12.00 | Central corneal nerve fibre loss, an early sign of diabetic neuropathy is supported by the AGEs - RAGE axis Simone Baltrusch, University Medicine Rostock, University of Rostock, Germany |
| 12.30 | Mechanism of Reversal of Insulin Resistance and Vascular Inflammation In Obesity By Glyoxalase 1 Inducer, Trans-Resveratrol-Hesperetin Paul John Thornalley, University of Warwick, UK |
| 12.30 - 13.30 | Lunch break and poster session Posters are displayed in Foyer |
| 13.30 - 17.00 | Session II: Mechanisms in Diabetic Complications |
| 13.30 | Senescent cells: an emerging target for disease of aging Darren Baker, Mayo Clinic College of Medicine, Rochester, USA |
| 14.00 | Proteostasis and AGEs Tilman Grune, DIfE - German Institute of Human Nutrition, Nuthetal, Germany |
| 14.30 | Metabolic reprogramming drives diabetic complications Subramaniam Pennathur, University of Michigan, Ann Arbor, USA |
| 15.00 | Coffee break |
| 15.30 | Posttranslation modifications in the pathophysiology of diabetic neuropathy Rohini Kuner, Department of Pharmacology, University of Heidelberg, Germany |
| 16.00 | Adipokine signaling and tumor complications Stephan Herzig, Helmholtz Center Munich, Institute for Diabetes and Cancer, Munich |
| 16.30 - 17.00 | Short Talks II (2 Talks, selected from abstracts) |
| 16.30 | Hepatic heat shock proteins in Diabetes and long term diabetic complications Maik Brune, University Hospital Heidelberg, Heidelberg, Germany |
| 16.45 | Hypoglycemia Promotes Inflammation By Recruitment Of Non-classical Monocytes And Cytotoxic Lymphocyte Subsets In Patients With Type 1 Diabetes Jaqueline Ratter, Radboud University Medical Center, Nijmegen, Netherlands |
| 17.00 | End of Sessions |
Friday, November 17th
| 08.00 - 08.50 | Registration |
| 09.00 - 12.30 | Session III: (Epi)Genetics and adipose tissue |
| 9.00 | Healthy adipocyte Jan Kopecký, Czech Academy of Sciences (CAS), Prague, Czech Republic |
| 9.30 | Transcriptional lineage determination of adipocyte precursor cells Susanne Mandrup, University of Southern Denmark, Odense, Denmark |
| 10.00 | Brown adipose tissue and lipid metabolism Jörg Heeren, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany |
| 10.30 | Coffee break |
| 11.00 | Epigenetics in obesity and diabetes Francesco Beguinot, University of Naples, Naples, Italy |
| 11.30 | Genetic and epigenetic predisposition for type 2 diabetes Annette Schürmann, DIfE - German Institute of Human Nutrition, Nuthetal, Germany |
| 12.00 - 12.30 | Short Talks III |
| 12.00 | Comparison of different human fat depots show distinct quantitative, qualitative and functional differences Benjamin Jaghutriz, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen & Dept. of Internal Medicine IV, Tuebingen, Germany |
| 12.15 | Novel Functions of Rab24 in Regulating Blood Glucose Homeostasis and Mitochondrial Activity in the Liver Anja Zeigerer, Institute for Diabetes and Cancer, Helmholtz Center Munich & German Center for Diabetes Research (DZD), Neuherberg, Germany |
| 12.30 - 13.30 | Lunch break and poster session Posters are displayed in Foyer |
| 13.30 - 15.00 | Session IV: Glucose Control by beta cells |
| 13.30 | Circadian control of lipid metabolism Gad Asher, Weizmann Institute of Science, Rehovot, Israel |
| 14.00 | Pancreatic island enhancers and diabetes susceptibility Ines Cebola, Imperial College London, London, UK |
| 14.30 | RNA binding proteins as metabolic regulators Markus Stoffel, ETH Zurich, Zurich, Switzerland |
| 15:00 | Growth Factor Regulation of Islet Biology Rohit Kulkarni, Harvard Medical School, Boston USA |
| 15.30 | End of Sessions |
| 15.30 - 16.00 | Farewell Coffee break and poster session Posters are displayed in Foyer |
| 16.00 - 17.00 | EASD Business Meeting |